Supplemental Data
PCT, PROLIFERATION, MONO, REGRESSION, BLOOD
Univariate logistic regression analyses of axillary lymph node metastasisCI: Confidence interval; OR: Odds ratio; Neu: Neutrophil; Lym: Lymphocyte; NLR: Neutrophil to lymphocyte ratio; PLT: Platelets; PLR: Platelet to lymphocyte ratio; Mono: Monocyte; LMR: Lymphocyte to monocyte ratio; A: Albumin; G: Globulin; A/G: Albumin to globulin ratio; AST: Aspartate transaminase; ALT: Alanine transaminase; LDH: Lactate dehydrogenase; HGB: Hemoglobin; HCT: Hematocrit; Eos: Eosinophil; Bas: Basophil; PCT: Thrombocytocrit; MPV: Mean platelet volume; PDW: The distribution width of platelets; BUN: Blood urea nitrogen; Src: Serum creatinine; CO2: Carbon dioxide; AG: Anion gap; PT: Prothrombin time; PPT: Percentage of prothrombin; INR: International normalized ratio; APTT: Activated partial thromboplastin time; TT: Thromboplastin time; FIB: Fibrinogen; cT: Clinical T stage; cN: Clinical N stage; pathGrade: Pathological grade; ER: Estrogen receptor; PR: Progesterone receptor; Ki67: Proliferation marker protein Ki67; HER2: Human epidermal growth factor receptor 2.Conflicts of interest: Authors declare no conflicts of interest.Funding: This study has received funding in part by the National Natural Science Foundation of China (81974420), and Natural Science Foundation of Hunan Province (2022JJ30979), the Xiangya-Peking University, Wei Ming Clinical and Rehabilitation Research Fund (No. xywm2015I35), and China Post-doctoral Science Foundation (2022M713536). The funding sources had no role in the study design, data collection, analysis, preparation of the manuscript, or decision to submit the manuscript for publication.Data availability: The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request